Nanoclay Promotes Mouse Cranial Bone Regeneration Mainly through Modulating Drug Binding and Sustained Release.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Regenerative Medicine

Background:

• Nanoclay (nanosilicates, NS) shows promise in bone tissue engineering for osteoinductivity, mechanical enhancement, and drug delivery.
• The precise mechanism of NS in in vivo bone regeneration remains largely undefined, hindering biomaterial design.
• Understanding NS mechanisms is vital for developing effective bone regeneration strategies.

Purpose of the Study:

• To elucidate the role of NS in osteoblastic differentiation and bone formation.
• To determine the essential function of NS in low-dose BMP2-induced cranial bone regeneration.
• To compare NS-mediated BMP2 delivery with conventional composite scaffolds.

Main Methods:

• Utilized mouse pre-osteoblasts (MC3T3-E1) and a mouse cranial bone defect model.
• Prepared biomimetic 3D gelatin nanofibrous scaffolds (GF) and NS-blended composite scaffolds (GF/NS).
• Investigated BMP2-induced osteoblastic differentiation and in vivo bone repair efficacy.

Main Results:

• NS enabled significant osteoblastic differentiation with a single BMP2 dose, unlike multiple doses without NS.
• Direct binding of BMP2 to NS in GF scaffolds ensured superior protection and sustained release compared to GF/NS composites.
• Only direct BMP2/NS binding treatment successfully repaired large cranial bone defects in vivo after 6 weeks.

Conclusions:

• Direct nanoclay-drug binding and sustained release are the most critical mechanisms for enhanced bone regeneration.
• The osteoinductive capacity of NS alone is less significant than its role in drug delivery for bone repair.
• This study clarifies the primary mechanism of NS in promoting bone regeneration, guiding future biomaterial development.